GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vetoquinol SA (FRA:8JM) » Definitions » YoY EPS Growth

Vetoquinol (FRA:8JM) YoY EPS Growth : -12.00% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Vetoquinol YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Vetoquinol's YoY EPS Growth for the quarter that ended in Dec. 2023 was -12.00%.

Vetoquinol's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was €1.98.

Vetoquinol YoY EPS Growth Historical Data

The historical data trend for Vetoquinol's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vetoquinol YoY EPS Growth Chart

Vetoquinol Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -20.92 -32.64 225.77 -23.54 15.76

Vetoquinol Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 525.00 -40.58 - 50.28 -12.00

Vetoquinol YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Vetoquinol's YoY EPS Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EPS Growth (A: Dec. 2023 )
=(Earnings per Share (Diluted) (A: Dec. 2023 )-Earnings per Share (Diluted) (A: Dec. 2022 ))/ | Earnings per Share (Diluted) (A: Dec. 2022 ) |
=(4.7-4.06)/ | 4.06 |
=15.76 %

Vetoquinol's YoY EPS Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EPS Growth (Q: Dec. 2023 )
=(Earnings per Share (Diluted) (Q: Dec. 2023 )-Earnings per Share (Diluted) (Q: Dec. 2022 )) / | Earnings per Share (Diluted) (Q: Dec. 2022 )) |
=(1.98-2.25)/ | 2.25 |
=-12.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vetoquinol YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Vetoquinol's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Vetoquinol (FRA:8JM) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vetoquinol SA (FRA:8JM) » Definitions » YoY EPS Growth
Comparable Companies
XPAR:BOI XPAR:EAPI XPAR:AB XPAR:MLCOT XPAR:ALRPD XTER:MRK ZTS NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ NBIX SZSE:000538 NSE:DIVISLAB BOM:532321 TSE:4507 HKSE:03692 VTRS TSE:4523
Traded in Other Exchanges
VETO:France
Address
Magny-Vernois, BP 189, Lure cedex, FRA, 70204
Website
http://www.vetoquinol.com
Vetoquinol SA operates is a France-based firm serving in the healthcare market. Its focus lies on developing and marketing veterinary drugs mainly in the European region and to a certain extent in America and Asia. Its portfolio of drugs entails anti-infectives, anti- pain inflammatory drugs, cardiovascular and nephrology treatment intended mainly for pets and livestock.

Vetoquinol (FRA:8JM) Headlines

No Headlines